The journal einstein (São Paulo) – e-ISSN 2317-6385 is dedicated to dissemination of high-quality scientific content that advances our understanding of human disease with the goal of improving prevention, care, diagnostics and treatment of patients globally.
Research indicates that in the beginning of the COVID-19 pandemic there was a decrease in number of tuberculosis diagnosis. This reduction has been suggested to have occurred due to social distancing and more constant hygiene routines, such as hand washing and sanitizing, as well as continued use of masks.(,)
[…]
The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?
BarrosGM. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo). 2022;20:eCE0196. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,Gabriel Martins de. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo)., v. 20, eCE0196, Nov. 2022. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,G.M. (2022). The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo).,20, eCE0196. https://doi.org/10.31744/einstein_journal/2022CE0196
Barros,Gabriel Martins de. The rise of tuberculosis: regression in combating advances as a legacy of COVID-19?. einstein (Sao Paulo). [online]. 2022, vol. 20, [cited 2025-09-06], eCE0196. Available from: <https://journal.einstein.br/article/the-rise-of-tuberculosis-regression-in-combating-advances-as-a-legacy-of-covid-19/>. ISSN 1679-4508. https://doi.org/10.31744/einstein_journal/2022CE0196
Figure 5
Risk of bias assessment of non-RCTs using the ROBINS-I tool
Non-RCT, nonrandomized controlled trial; ROBINS-I, Risk of Bias in Non-Randomized Studies-of Interventions